Abstract

Present investigation showing confirmatory evidence for complex formation of Diclofenac sodium (Dic) with Go-Ghrita (GG) by various sophisticated techniques like FT-IR, In-vitro release study, DSC, X-ray diffraction and SEM other than 1 NMR (which is reported earlier). Diclofenac sodium binary mixture in (1:0.5), (1:1), (1:2), (1:3) w/w proportions were prepared by adding to molten Go-Ghrita kept over a water bath at 65-70 o C with continuous stirring. Organoleptic and Physico-chemical properties of GG (procured from Magan Sangrahalaya, Wardha) were as per the specifications given in Ayurvedic Pharmacopoeia (AP) and Indian Pharmacopoeia (IP). All proportions were subjected for FT-IR and in-vitro release behaviour (SGF, P H 1.2 for 2 Hrs and SIF, P H 6.8 for 7 Hrs) and on basis of it, optimized (1:1) w/w proportions were further analyzed and characterized for Differential Scanning Calorimetry, X-ray diffraction and Scanning Electron Microscopy. Carbonyl stretching of benzene acetic acid group to slight higher frequency 9.23 % cm -1 (increase) and (–C=O) linked (-OH) band stretching to slight lower frequency 0.57 cm -1 (decrease) shown in FT-IR spectra, supported by in-vitro release of Diclofenac sodium 99.13±0.31% of (1:1) w/w in sustenance form than remaining. Retention of peaks with lesser intensity in binary mixture of drug with GG, revealed crystalline as well as non-crystalline (amorphous) nature in X-RD, Slight lowering of 17.6 0 C Tm and enthalpy change of 8.51 % (loss) in DSC, and entrapment of Diclofenac sodium crystals in Dic-GG binary mixture shown in SEM photographs, reflecting possible evidence for the formation of inclusion type complex between Diclofenac sodium and GG.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.